Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Aurobindo Pharma has informed about notice issued for the attention of equity shareholders of the company on 15.11.2017 which was published on 18.11.2017, intimating that the equity shares in respect of which dividend remain unclaimed for seven consecutive years, would be transferred to Investor Education and Protection Fund (IEPF), in Business Standard (English newspaper) and Andhra Prabha (Telugu newspaper).
The above information is a part of company’s filings submitted to BSE.
